Mismatch repair genes status in sporadic Saudi colorectal cancer patients by Manar Ata et al.
POSTER PRESENTATION Open Access
Mismatch repair genes status in sporadic Saudi
colorectal cancer patients
Manar Ata1*, Ashraf Dallol1, Jaudah Al-Maghrabi2, Abdulrahmn Al-Sibiany3, Mahmoud Al-Ahwal4,
Mohammed Al-Qahtani1, Abdelbaset Buhmeida1
From 2nd International Genomic Medical Conference (IGMC 2013)
Jeddah, Kingdom of Saudi Arabia. 24-27 November 2013
Background
Colorectal cancer (CRC) is becoming a major public
health problem globally [1]. It ranks first in men and
third in women of Saudi population according to Saudi
Cancer Registry 2009 [2]. Many efforts have been direc-
ted toward assessment of best strategies for establishing
molecular prognostic model [3,4]. In our study, we
aimed to assess the prevalence of Mismatch Repair
(MMR) genes defects in CRC and evaluate the concor-
dance rate between Microsatellite Instability (MSI) and
Immunohistochemistry (IHC).
Materials and methods
Two techniques were used: IHC using antibodies for
MLH1 and MSH2 gene proteins and MSI tests using a
panel of five Microsatellites’ markers (BAT25, BAT26,
D5S346, D2S123 and D17S250) that have been validated
and recommended for tumor characterization as MS-
stable, MSI-H or MSI-L. DNA samples from tumors
and normal tissues of 83 patients undergoing curative
surgery of sporadic CRC were amplified using Polymer-
ase chain reaction (PCR). PCR products were run on
ABI prism 310 sequencer and GeneScan; version 310
software was used for analysis. Paraffinized tissue sec-
tions slides from the same patients tissues were used for
IHC detection of MLH1 and MSH2 proteins.
Results
The prevalence of MSI-H, MSI-L and MS-stable were 44.6
%, 31.3 % and 24.1 % respectively. IHC identified 50 cases
(60.2%) with loss of expression of MLH1 and 40 cases
(48.2%) with loss of expression of MSH2. Concordance
rate between MSI and IHC is 55.4%. Furthermore, 28.9%
of no concordance is attributed to other MMR genes not
included in our study.
Conclusions
MSI and IHC are complementary useful techniques for
evaluation of MMR status. Further study with a large
cohort is needed to evaluate correlation with clinico-
pathological characteristics and to be used as prognostics.
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